Oxybutynin Chloride | US Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Oxybutynin Chloride
US Patents

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

Contact Supplier

Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

Contact Supplier

FAMAR CDMO- From early development to commercial manufacturing.

Contact Supplier

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Oxybutynin Chloride

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

24 API Suppliers, 13 USDMF, 10 CEP/COS, 3 JDMF, 2 EU WC, 1 KDMF, 11 NDC API, 10 Listed Suppliers, $ API Reference Price

24 API Suppliers
13 USDMF
10 CEP/COS
3 JDMF
2 EU WC
1 KDMF
11 NDC API
10 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

1 Drugs in Development

1 Drugs in Development

INTERMEDIATES

2 Intermediate Suppliers

2 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

93 FDF Dossiers, 61 FDA Orange Book, 12 Europe, 10 Canada, 4 South Africa, 6 Listed Dossiers

93 FDF Dossiers
61 FDA Orange Book
12 Europe
10 Canada
4 South Africa
6 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET, EXTENDED RELEASE;ORAL - 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, GEL;TRANSDERMAL - 10% (100MG/PACKET) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET, EXTENDED RELEASE;ORAL - 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, EXTENDED RELEASE;ORAL - 15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, EXTENDED RELEASE;ORAL - 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
GEL;TRANSDERMAL - 10% (100MG/PACKET) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 4 Evonik, 2 Rochem International Inc, 20 SPI Pharma, 2 Seqens, 5 DKSH, 7 Faran Shimi Pharmaceutical, 1 Boai NKY Pharmaceuticals Ltd, 7 Gangwal Healthcare, 7 Nanjing Well Pharmaceutical, 2 Pfanstiehl, 1 Capital Farma, 1 ACG Worldwide, 12 Actylis, 1 Aeon Procare, 2 Alcedo Pharmachem, 8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 30 BASF, 1 Clariant, 14 Corel Pharma Chem, 7 DFE Pharma, 3 Doshion Polyscience, 2 Finar, 12 Gangwal Chemicals, 9 Ideal Cures Pvt Ltd, 5 Ingredion Pharma Solutions, 37 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 16 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nomisma Healthcare, 2 Novo Excipients, 3 Pharmatrans-Sanaq, 8 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 29 Roquette, 14 Seppic, 7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 12 Sigachi Industries, 2 The Dow Chemical Company, 2 Valens Pharmachem, 5 Vasa Pharmachem, 1 Vertellus, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

85 Fillers, Diluents & Binders, 66 Coating Systems & Additives, 42 Controlled & Modified Release, 35 Direct Compression, 31 Disintegrants & Superdisintegrants, 30 Solubilizers, 28 Granulation, 28 Taste Masking, 27 Film Formers & Plasticizers, 26 Parenteral, 25 Thickeners and Stabilizers, 24 Lubricants & Glidants, 18 Topical, 17 Chewable & Orodispersible Aids, 16 Co-Processed Excipients, 10 Emulsifying Agents, 6 API Stability Enhancers, 5 Empty Capsules, 5 Surfactant & Foaming Agents, 5 Coloring Agents, 5 Rheology Modifiers, 4 Vegetarian Capsules, 1 Soft Gelatin

85 Fillers, Diluents & Binders
66 Coating Systems & Additives
42 Controlled & Modified Release
35 Direct Compression
31 Disintegrants & Superdisintegrants
30 Solubilizers
28 Granulation
28 Taste Masking
27 Film Formers & Plasticizers
26 Parenteral
25 Thickeners and Stabilizers
24 Lubricants & Glidants
18 Topical
17 Chewable & Orodispersible Aids
16 Co-Processed Excipients
10 Emulsifying Agents
6 API Stability Enhancers
5 Empty Capsules
5 Surfactant & Foaming Agents
5 Coloring Agents
5 Rheology Modifiers
4 Vegetarian Capsules
1 Soft Gelatin

DIGITAL CONTENT

17 NEWS #PharmaBuzz

17 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 13 Finished Drug Prices

2 US Medicaid Prescriptions
13 Finished Drug Prices

MARKET PLACE

8 APIs

8 APIs

PATENTS & EXCLUSIVITIES

3 US Patents, 8 Health Canada Patents

3 US Patents
8 Health Canada Patents

REF. STANDARDS & IMPURITIES

1 USP, 1 Others

1 USP
1 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 648 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

3 All

01 3ABBVIE

filter Patent Number Reset all filters

3 All

01 18920392

02 19259388

03 110449173

filter API Patent Reset all filters

3 All

01 3Blank

filter FDF Patent Reset all filters

3 All

01 1Y

02 2Blank

filter Expiration Date Reset all filters

3 All

01 22029-11-06

02 12031-03-26

Product Main Page

01

ABBVIE

The Generic Rx Session

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2031-03-26

OXYBUTYNIN CHLORIDE

US Patent Number : 8920392

Drug Substance Claim :

Drug Product Claim :

Application Number : 22204

Patent Use Code : U-1644

Delist Requested :

Patent Use Description : TREATMENT OF OVERACTIV...

Patent Expiration Date : 2031-03-26

Abbvie Company Banner

Product Web Link

Digital Content

Corporate PDF

02

ABBVIE

The Generic Rx Session

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2029-11-06

OXYBUTYNIN CHLORIDE

US Patent Number : 10449173

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 22204

Patent Use Code : U-2637

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2029-11-06

Abbvie Company Banner

Product Web Link

Digital Content

Corporate PDF

03

ABBVIE

The Generic Rx Session

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2029-11-06

OXYBUTYNIN CHLORIDE

US Patent Number : 9259388

Drug Substance Claim :

Drug Product Claim :

Application Number : 22204

Patent Use Code : U-1644

Delist Requested :

Patent Use Description : TREATMENT OF OVERACTIV...

Patent Expiration Date : 2029-11-06

Abbvie Company Banner

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
ASK US!